Arkolith/Insider Trading/KIN/Form 4

Elanco Animal Health Inc

10% OwnerKindred Biosciences, Inc. (KIN) · full profile →Form 4 · filed Aug 30, 2021
Net Buying
Open-Market Buys
$421.0M
Open-Market Sells
$0
Net Open-Market Flow
$421.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2021Buy(P)45.5M$9.25$421.0M10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-110763) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML